Volta Medical’s afib AI shows gains in cardiac ablation study
The company’s randomized clinical trial, published in Nature Medicine, tested the addition of AI-targeted heart ablations to conventional pulmonary vein isolation.
The company’s randomized clinical trial, published in Nature Medicine, tested the addition of AI-targeted heart ablations to conventional pulmonary vein isolation.
